Zoreeda

Zoreeda (fluticasone propionate and salmeterol) is an inhaled corticosteroid and long-acting beta agonist combination used for maintenance treatment of asthma and COPD. This prescription medication helps reduce inflammation and open airways for easier breathing. Always follow your healthcare provider's guidance when using Zoreeda.

Zoreeda combines fluticasone propionate, an inhaled corticosteroid that reduces airway inflammation, with salmeterol, a long-acting beta agonist that helps keep airways open. It is prescribed for daily maintenance treatment of asthma in patients aged 4 years and older, and to reduce flare-ups in people with chronic obstructive pulmonary disease (COPD). This medication is not intended for sudden breathing problems or as a rescue inhaler.

When used as directed, Zoreeda helps control symptoms such as wheezing, shortness of breath, and chest tightness by reducing swelling in the airways and relaxing the muscles around them. Regular use may improve breathing over time and reduce the frequency of asthma attacks. Some users may experience mild throat irritation or a change in taste.

Store Zoreeda at room temperature away from moisture and heat. Keep the inhaler away from children and pets. Rinse your mouth with water after each use to reduce the risk of oral thrush. Do not use Zoreeda if you are allergic to fluticasone, salmeterol, or any component of the inhaler. Always follow the prescribed dosage and consult your healthcare provider before starting or stopping this medication.

Zoreeda may interact with certain medications, including strong CYP3A4 inhibitors like ketoconazole or ritonavir, which can increase the risk of side effects. Beta-blockers, such as propranolol, may reduce the effectiveness of salmeterol. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using. Avoid using other inhaled corticosteroids or long-acting beta agonists unless directed by your doctor.